TELMISARTAN

Generic: TELMISARTAN

Solco Healthcare USManufacturer
ORALRoute
TELMISARTANActive Substance
2017-05-03Original Approval

TELMISARTAN is FDA application ANDA207882, sponsored by PRINSTON. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
FATIGUE
1,516 reports
2
NAUSEA
1,409 reports
3
DRUG INEFFECTIVE
1,287 reports
4
DIARRHOEA
1,267 reports
5
HEADACHE
1,250 reports
6
DYSPNOEA
1,206 reports
7
OFF LABEL USE
1,193 reports
8
FALL
1,166 reports
9
ARTHRALGIA
1,072 reports
10
BLOOD PRESSURE INCREASED
1,042 reports